Owner
CurrentLegal representation in the United States and Great Britain in matters concerning toxic exposure; pharmaceutical liability; personal injury; products liability; intellectual property; commercial disputes; oil and gas disputes; medical malpractice; maritime law; and international arbitration. Clients include individuals, businesses of all sizes, and governmental entities. Verdicts exceed over one billion dollars in plaintiffs’ representation. Significant verdicts also in defense representation. Noteworthy verdicts:Mark successfully served as co-lead counsel in a November 2021 trial, the first exploring allegations that large pharmacy chains fueled the opioid crisis. Following six weeks of testimony, pharmacy giants CVS Health, Walgreens and Walmart were found liable for contributing to the epidemic in two Ohio counties.In July 2018, Mark and his trial team secured a record-setting $4.69 billion verdict for 22 women and their families who alleged that decades of daily use of Johnson & Johnson’s asbestos-laden talcum powder products caused the women’s ovarian cancer. In November 2017, Mark helped secure a $247 million verdict against DePuy Orthopaedics Inc., a subsidiary of Johnson & Johnson, over Pinnacle metal-on-metal hip implants.Mark secured two verdicts in March and December 2016, both against DePuy and Johnson & Johnson. The March verdict was recognized by the National Law Journal as the Outstanding Medical Device Award for 2016 and as one of the Top 50 Verdicts of the Year. In the December verdict, Mark won over $1 billion, the fourth-largest verdict in the nation for that year.Mark secured a verdict exceeding $9 billion against Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. over the diabetes drug Actos.Mark won the largest verdict in Texas in 2016, according to VerdictSearch and Texas Lawyer, as well as the third largest verdict with $1 billion and $502 million respectively.